CERULEAN SCIENTIFIC Trademark
Trademark Overview
On Wednesday, November 29, 2023, a trademark application was filed for CERULEAN SCIENTIFIC with the United States Patent and Trademark Office. The USPTO has given the CERULEAN SCIENTIFIC trademark a serial number of 98290810. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, July 1, 2024. This trademark is owned by FreeFlow Medical Devices LLC. The CERULEAN SCIENTIFIC trademark is filed in the Medical Instrument Products category with the following description:
Medical devices
General Information
Serial Number | 98290810 |
Word Mark | CERULEAN SCIENTIFIC |
Filing Date | Wednesday, November 29, 2023 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Monday, July 1, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
NOT AVAILABLE | "SCIENTIFIC" |
Goods and Services | Medical devices |
Classification Information
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, November 29, 2023 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | FreeFlow Medical Devices LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Durham, NC 27701 |
Trademark Events
Event Date | Event Description |
Wednesday, November 29, 2023 | NEW APPLICATION ENTERED |
Saturday, February 17, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, June 27, 2024 | ASSIGNED TO EXAMINER |
Monday, July 1, 2024 | NON-FINAL ACTION WRITTEN |
Monday, July 1, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, July 1, 2024 | NON-FINAL ACTION E-MAILED |